Liangjing Wang

24PUBLICATIONS
62CO-AUTHORS
Innate immunityHaematological tumoursMolecular targetsMicrobial geneticsProteomics and metabolomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 18, 2026
Consolidation Therapy of Probiotics With Rifaximin Prevent Relapse in Rifaximin-Responsive Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Randomized Clinical Trial.

|Jun 04, 2026
Gut pathobionts translocate into liver and reshape intrahepatic microbiome to facilitate hepatocellular carcinoma.

|Mar 01, 2026
Targeting NAT10 alleviates colonic senescence and elderly-onset colitis by disrupting N4-acetylation of DYRK1A.

Jingyu Chen, Meng Xue, Shuyi Mi

|Jun 30, 2025
Microbiota-dependent metabolites - New engine for T cell warriors.

Yang Tang, Anbo Fu, Liangjing Wang

|Jan 10, 2025
Comprehensive discovery and functional characterization of the noncanonical proteome.

Chengyu Shi, Fangzhou Liu, Xinwan Su

|Dec 12, 2023
Microbiota: A key factor affecting and regulating the efficacy of immunotherapy.

Yao Jiang, Dingjiacheng Jia, Yong Sun

Pageof 4

Frequent Collaborators

6 joint publications

Tianhua Zhou

5 joint publications

Qiwei Ge

5 joint publications

Wei Zhuo

4 joint publications

Dingjiacheng Jia